KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Equity (2016 - 2025)

Historic Return on Equity for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to 0.41%.

  • Ionis Pharmaceuticals' Return on Equity rose 3700.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 3700.0%. This contributed to the annual value of 0.93% for FY2024, which is 1700.0% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Return on Equity of 0.41% as of Q3 2025, which was up 3700.0% from 0.49% recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Return on Equity peaked at 0.01% during Q3 2022, and registered a low of 1.31% during Q2 2024.
  • Its 5-year average for Return on Equity is 0.65%, with a median of 0.73% in 2024.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Return on Equity tumbled by -11400bps in 2021, and later soared by 11100bps in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' Return on Equity (Quarter) stood at 0.05% in 2021, then tumbled by -924bps to 0.46% in 2022, then plummeted by -126bps to 1.05% in 2023, then soared by 30bps to 0.73% in 2024, then skyrocketed by 43bps to 0.41% in 2025.
  • Its Return on Equity was 0.41% in Q3 2025, compared to 0.49% in Q2 2025 and 0.86% in Q1 2025.